논문 목록
Issue Date Title Journals
2024-05 First-year cumulative myeloperoxidase-ANCA titres are associated with all-cause mortality in patients with microscopic polyangiitis Clinical and Experimental Rheumatology
2024-05 Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis Clinical and Experimental Rheumatology
2024-05 Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria The Korean Journal of Internal Medicine
2024-03 Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Medicina (Kaunas, Lithuania)
2024-02 Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis Zeitschrift für Rheumatologie
2024-02 Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic Zeitschrift für Rheumatologie
2024-02 Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort Seminars in Arthritis and Rheumatism
2024-01 Antineutrophil cytoplasmic antibody‑associated vasculitis classification by cluster analysis based on clinical phenotypes: a single‑center retrospective cohort study Clinical Rheumatology
2023-12 Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis Arthritis Research & Therapy
2023-11 IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis Journal of Clinical Medicine
2023-11 Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study Journal of Clinical Medicine
2023-10 Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis Heliyon
2023-10 Hepatic steatosis index at diagnosis has the potential for forecasting end-stage kidney disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis 대한류마티스학회지
2023-10 Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis Yonsei Medical Journal
2023-09 A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis Asian Pacific Journal of Allergy and Immunology
2023-09 Renal histopathological predictors of end‑stage kidney disease in ANCA‑associated vasculitis with glomerulonephritis: a single‑centre study in Korea Scientific Reports
2023-09 Association between computed tomography-assessed sarcopenia and mortality in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis International Journal of Rheumatic Diseases
2023-09 Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Journal of Clinical Medicine
2023-09 Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis Frontiers in Medicine
2023-08 Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis A Korean Single-Center Study Journal of Clinical Rheumatology
2023-08 A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis Therapeutic Advances in Musculoskeletal Disease
2023-06 Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Journal of Clinical Medicine
2023-05 New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis Frontiers in Medicine
2023-05 Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody–associated vasculitis Annals of Clinical Biochemistry
2023-04 Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis Clinical and Experimental Rheumatology
2023-04 Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis Clinical and Experimental Rheumatology
2023-04 Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis Clinical and Experimental Rheumatology
2023-04 Acute coronary syndrome in antineutrophil cytoplasmic antibody-associated vasculitis: a Korean single-centre cohort study Journal of Rheumatic Diseases
2023-03 Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria Rheumatology (United Kingdom)
2023-02 The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Journal of Rheumatology
2023-01 Cancer‑associated vasculitides: a single‑centre case series Clinical Rheumatology
2023-01 Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center 대한류마티스학회지
2023-01 Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria Yonsei Medical Journal
2022-12 Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis Scientific Reports
2022-11 Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis Korean Journal of Internal Medicine
2022-11 A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis Scientific Reports
2022-11 Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis In Vivo
2022-11 BVAS version 3 and BVAS/GPA: standing on the same line? CLINICAL RHEUMATOLOGY
2022-10 Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis Annals of Palliative Medicine
2022-10 Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis Zeitschrift fur Rheumatologie
2022-09 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al Annals of the Rheumatic Diseases
2022-08 Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody‑associated vasculitis in non‑diabetic patients BMC NEPHROLOGY
2022-07 Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis Journal of Rheumatic Diseases
2022-07 Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis JOURNAL OF RENAL NUTRITION
2022-07 Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2 Journal of Clinical Medicine
2022-07 Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis JOURNAL OF CLINICAL LABORATORY ANALYSIS
2022-07 Serum albumin, prealbumin, and ischemiamodified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study PLOS ONE
2022-07 Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002–2018 South Korea National Health Insurance Database Frontiers in medicine
2022-06 Is thyroid autoimmunity a predisposing factor for fibromyalgia? A systematic review and meta-analysis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022-06 Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018 ARTHRITIS RESEARCH & THERAPY
2022-06 Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease FRONTIERS IN CARDIOVASCULAR MEDICINE
2022-06 Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnostics
2022-05 Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single- Centre Observational Study JOURNAL OF IMMUNOLOGY RESEARCH
2022-05 New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis JOURNAL OF CLINICAL LABORATORY ANALYSIS
2022-05 Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022-05 Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022-04 Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea Stroke and Vasular Neurology
2022-04 Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Medicina (Kaunas, Lithuania)
2022-04 Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome RHEUMATOLOGY
2022-04 Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? RHEUMATOLOGY
2022-04 Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience LUPUS
2022-04 Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis Journal of Clinical Medicine
2022-03 Aortic valve surgery in patients with Takayasu’s arteritis: a nationwide analysis of 1,197 patients during a 9-year period CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022-03 A retrospective analysis of antineutrophil cytoplasmic antibodyassociated vasculitis aiming for an equation prediction end-stage renal disease CLINICAL RHEUMATOLOGY
2022-02 Clinical application of low erythrocyte sedimentation rate/ high C-reactive protein to antineutrophil cytoplasmic antibody-associated vasculitis JOURNAL OF CLINICAL LABORATORY ANALYSIS
2022-02 Serum vitamin D level correlates with disease activity and healthrelated quality of life in antineutrophil cytoplasmic antibody-associated vasculitis ZEITSCHRIFT FUR RHEUMATOLOGIE
2022-02 Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody‑associated vasculitis RHEUMATOLOGY INTERNATIONAL
2022-01 Drug Survival of Biologic Therapy in Elderly Patients With Rheumatoid Arthritis Compared With Nonelderly Patients Results From the Korean College of Rheumatology Biologics Registry Journal of Clinical Rheumatology
2022-01 Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis Journal of Rheumatic Diseases
2022-01 GeTe Nanosheets as Theranostic Agents for Multimodal Imaging and Therapy of Inflammatory Bowel Disease ADVANCED FUNCTIONAL MATERIALS
2021-12 A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis RHEUMATOLOGY
2021-12 Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Journal of Clinical Medicine
2021-12 Prevalence of Osteopenia in Drug-Naive Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis A Monocentric Study JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
2021-11 Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis JOURNAL OF CLINICAL LABORATORY ANALYSIS
2021-11 Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis YONSEI MEDICAL JOURNAL
2021-10 KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities 대한류마티스학회지
2021-10 Association of Serum Biomarkers With Pulmonary Involvement of Rheumatoid Arthritis Interstitial Lung Disease: From KORAIL Cohort Baseline Data 대한류마티스학회지
2021-10 Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
2021-09 Evaluation of body composition using computed tomography in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis KOREAN JOURNAL OF INTERNAL MEDICINE
2021-09 Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis MEDICINE
2021-09 Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody–associated vasculitis CLINICAL RHEUMATOLOGY
2021-08 Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis JOURNAL OF CLINICAL LABORATORY ANALYSIS
2021-08 Systemic inflammation response index predicts all‑cause mortality in patients with antineutrophil cytoplasmic antibody‑associated vasculitis INTERNATIONAL UROLOGY AND NEPHROLOGY
2021-07 Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2021-07 Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis MEDIATORS OF INFLAMMATION
2021-07 Fibrosis‑5 predicts end‑stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis without substantial liver diseases CLINICAL AND EXPERIMENTAL MEDICINE
2021-07 Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis PLOS ONE